PEOPLE with leukaemia could in future be spared repeated courses of debilitating chemotherapy and have a far higher chance of a complete cure.
A new therapy is being tested that relies on inducing the body’s own immune cells to home in on cancer cells. And the approach, announced last week by a team at the University of California in San Diego (UCSD), should be suitable for all types of leukaemia, unlike many other kinds of experimental immunotherapy that only work against subsets of cancers with particular cell surface proteins.
The researchers grew patients’ leukaemia cells side by side with their…
